Project Grant HT94252410526
Award Date 6/1/24
Completion Date 5/31/27
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $650,138 Project Grant to The Cleveland Clinic Foundation on September 1, 2024. The grant will fund a 2-year study focused on developing biomarkers to assess patient response to neurorestorative therapies for cervical spinal cord injuries. The Cleveland Clinic Foundation, a non-profit academic medical center, will leverage its expertise in neuroscience research to advance this...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Cleveland Clinic Foundation a $999,566 project grant effective November 1, 2025, through October 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports a three-year research initiative focused on magnetic resonance imaging-guided transcriptomic analysis of spinal cord neurodegeneration and demyelination in multiple sclerosis. This project represents a hypothesis-driven...
- The Department of Defense's Defense Health Agency awarded The Cleveland Clinic Foundation a $383,740 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the research and development of a "Novel Graft-Localized Drug Delivery Platform for Attenuating Innate Inflammation and Optimizing Immunosuppression in Vascularized Composite Allotransplantation." This project aims to develop innovative medical...
- The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $2,602,024 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2024, will fund research on the "Role of Stress in the Degradation of Intestinal IgA and Intestinal Health" over a 4-year period ending on September 29, 2028. As a prominent academic medical center, The Cleveland Clinic Foundation...
- The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
- Federal Grant Award Summary The Cleveland Clinic Foundation received a $799,998 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 15, 2025, through September 14, 2028. The grant supports research focused on "Strategies Enhancing Spinal Plasticity to Promote Recovery from Spinal Cord Injury," with work to be performed at the organization's Cleveland, Ohio location. This research...
- The Defense Health Agency awarded a $1,139,124 Project Grant to The Cleveland Clinic Foundation to conduct research on the novel nuclear localization of the complement regulator CD55 and its potential to disrupt ovarian cancer progression. This 4-year grant, beginning on May 1, 2025, is funded through the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader...
- This federal Project Grant award of $1,200,000 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation supports research to develop therapeutic strategies to disrupt the CX26-FAK-NANOG complex in order to attenuate cancer stem cell self-renewal and triple-negative breast cancer progression. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative...
- Project Grant Summary The Cleveland Clinic Foundation received a $1.92M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. The grant funds research to develop NEUPRON for acute spinal cord injury treatment, with a specific focus on identifying and validating surrogate biomarkers that can measure treatment efficacy. This research initiative aligns with the DHA's strategic...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,159,998.00 to The Cleveland Clinic Foundation, a non-profit academic medical center, to fund a research project titled "THERAPEUTIC IMMUNOSTIMULATORY MICROBES FOR TREATMENT OF OVARIAN CANCER". The award, which runs from September 1, 2024 to August 31, 2028, will support the Foundation's innovative biomedical research into developing...